The global embolic protection devices market is projected to reach USD 604.9 million by 2023 from USD 405.5 million in 2018, at a CAGR of 8.3%. Factors such as the rising incidence of cardiovascular and neurovascular diseases, growing funding and investments, launch of technologically advanced embolic protection devices, and the rising demand for minimally invasive procedures are expected to drive the growth of the market.
Download FREE Brochure@
https://www.marketsandmarkets.com/pdfdownload.asp?id=158143803
In this report, the embolic protection devices market is segmented based on type & material, application, indication, end user, and region. On the basis of type, the distal filter devices segment accounted for the largest share of the global embolic protection devices market in 2017. The large share and high growth of this segment can primarily be attributed to the increasing number of research activities aimed at the clinical evaluation of distal filtration devices, the procedural benefits offered by these devices (such as ease of use, enhanced visibility, and crossing profile), and the strengthening distribution networks of device manufacturers across major markets such as the US, Japan, and Europe. On the basis of material, nitinol segment is poised to grow at the fastest growth rate in the embolic protection devices market. The super-elastic material and the braided nitinol design provides full wall apposition and this quality is expected to drive the growth of nitinol in the embolic protection devices market.
By application, the embolic protection market is segmented into cardiovascular, neurovascular, and peripheral vascular diseases. The neurovascular diseases segment is poised to grow at the fastest growth rate in the embolic protection devices market. With the increasing target patient population, the demand for embolic protection devices for the treatment of neurovascular diseases is expected to increase during the forecast period.
Based on the indications, the embolic protection devices segment is further segmented into percutaneous coronary intervention, transcatheter aortic valve replacement (TAVR), carotid artery diseases, saphenous vein graft disease, and other indications. The percutaneous coronary intervention segment accounted for the largest share of the global embolic protection devices market. The large share of this segment can primarily be attributed to the increasing prevalence of CAD and the rising preference for minimally invasive procedures globally.
Among end users, hospitals is the fastest growing end-user segment in the embolic protection devices market during the forecast period. The market for this segment is mainly driven by factors such as the growing number of angioplasty procedures performed in hospitals, rising incidence of chronic vascular diseases, favorable reimbursement scenario in developed countries, increasing number of hospitals, and increasing government initiatives to provide quality treatment for cardiovascular diseases.
Geographically, the embolic protection devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Asia Pacific is poised to grow at the highest CAGR during the forecast period, mainly due to the growing number of prescriptions for people aged 65 or above, increasing healthcare spending, rising healthcare costs, and increasing target population.
Download FREE Brochure@
https://www.marketsandmarkets.com/pdfdownload.asp?id=158143803
In this report, the embolic protection devices market is segmented based on type & material, application, indication, end user, and region. On the basis of type, the distal filter devices segment accounted for the largest share of the global embolic protection devices market in 2017. The large share and high growth of this segment can primarily be attributed to the increasing number of research activities aimed at the clinical evaluation of distal filtration devices, the procedural benefits offered by these devices (such as ease of use, enhanced visibility, and crossing profile), and the strengthening distribution networks of device manufacturers across major markets such as the US, Japan, and Europe. On the basis of material, nitinol segment is poised to grow at the fastest growth rate in the embolic protection devices market. The super-elastic material and the braided nitinol design provides full wall apposition and this quality is expected to drive the growth of nitinol in the embolic protection devices market.
By application, the embolic protection market is segmented into cardiovascular, neurovascular, and peripheral vascular diseases. The neurovascular diseases segment is poised to grow at the fastest growth rate in the embolic protection devices market. With the increasing target patient population, the demand for embolic protection devices for the treatment of neurovascular diseases is expected to increase during the forecast period.
Based on the indications, the embolic protection devices segment is further segmented into percutaneous coronary intervention, transcatheter aortic valve replacement (TAVR), carotid artery diseases, saphenous vein graft disease, and other indications. The percutaneous coronary intervention segment accounted for the largest share of the global embolic protection devices market. The large share of this segment can primarily be attributed to the increasing prevalence of CAD and the rising preference for minimally invasive procedures globally.
Among end users, hospitals is the fastest growing end-user segment in the embolic protection devices market during the forecast period. The market for this segment is mainly driven by factors such as the growing number of angioplasty procedures performed in hospitals, rising incidence of chronic vascular diseases, favorable reimbursement scenario in developed countries, increasing number of hospitals, and increasing government initiatives to provide quality treatment for cardiovascular diseases.
Geographically, the embolic protection devices market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Asia Pacific is poised to grow at the highest CAGR during the forecast period, mainly due to the growing number of prescriptions for people aged 65 or above, increasing healthcare spending, rising healthcare costs, and increasing target population.
Know More:
No comments:
Post a Comment